Tag: Leading Genetics Research Award

Yasemin Çakır Kıymaz | Biochemistry, Genetics and Molecular Biology | Academic Research Impact Award

Published on by World Science Awards

Dr. Yasemin Çakır Kıymaz | Biochemistry, Genetics and Molecular Biology | Academic Research Impact Award

Sivas at Cumhuriyet University, Turkey

Dr. Yasemin Çakır Kıymaz is an accomplished Assistant Professor specializing in Infectious Diseases and Clinical Microbiology. She has dedicated her career to advancing medical research and education, with a particular focus on public health and infectious diseases. Her academic journey and professional expertise reflect a strong commitment to addressing critical healthcare challenges, including the prognosis of diseases such as Crimean-Congo Hemorrhagic Fever. Dr. Kıymaz has supervised impactful research projects and has served as a leader in infection control efforts. With memberships in numerous national and international professional organizations, she is recognized for her contributions to the scientific community. Her work bridges clinical practice and academic research, making her a valuable asset in medical science.

Profession Profile

Education

Dr. Kıymaz earned her bachelor’s degree in medicine in 2008, followed by a specialization in Infectious Diseases in 2016. Her academic achievements culminated in a thesis that explored factors affecting hospitalization durations of COVID-19 patients, reflecting her early contributions to emerging global health crises. She achieved her Assistant Professorship in 2021 and continues to build upon her expertise through academic and research endeavors. Her educational background underpins her robust understanding of infectious diseases and her commitment to improving patient care and health outcomes.

Professional Experience

Dr. Kıymaz has a comprehensive professional background, beginning as a Research Assistant at Düzce University in 2016, where she worked in the Department of Infectious Diseases and Clinical Microbiology. She later served as an Assistant Professor at Yozgat Bozok University from January to September 2023 before joining Sivas Cumhuriyet University in September 2023. Additionally, she chaired the Infection Control Committee at various institutions, leading efforts to implement effective infection prevention protocols. Her roles demonstrate a combination of academic leadership, research excellence, and practical contributions to healthcare.

Research Interests

Dr. Kıymaz’s research interests revolve around infectious diseases, with a focus on non-coding RNA and its role in the prognosis of diseases like Crimean-Congo Hemorrhagic Fever. Her work also extends to public health issues such as antimicrobial resistance, infection control, and vaccination strategies. Her dedication to exploring the molecular and clinical aspects of infectious diseases positions her as a significant contributor to advancing knowledge in her field.

Research Skills

Dr. Kıymaz possesses advanced research skills, including project management, clinical data analysis, and molecular biology techniques. She is adept at supervising theses and leading research projects, as evidenced by her work on the role of RNA in disease prognosis. Her expertise in infection control, epidemiology, and public health further underscores her technical and analytical abilities in addressing complex healthcare challenges.

Awards and Honors

Dr. Kıymaz has been recognized for her contributions to the medical field through memberships in esteemed organizations such as the European AIDS Clinical Society and the European Society of Clinical Microbiology and Infectious Diseases. These affiliations highlight her standing in the global research community. Her leadership in infection control committees and supervision of nationally funded research projects also reflects her recognition as a leader in her field.

Conclusion

Dr. Yasemin Çakır Kıymaz is a highly capable researcher and educator in the field of infectious diseases. Her academic achievements, professional experience, and dedication to impactful research make her a deserving candidate for prestigious awards. While her focus on public health and infection control is commendable, her potential for broader international recognition and interdisciplinary research marks her as a rising star in medical science.

Publication Top Notes

  1. Title: Mortality rates and risk factors associated with mortality in patients with stenotrophomonas maltophilia primary Bacteraemia and Pneumonia
    Authors: Hasbek, M., Aldemir, Ö., Çakır Kıymaz, Y., Yıldırım, D., Büyüktuna, S.A.
    Year: 2025
  2. Title: The great tularemia outbreak in Sivas: Evaluation of 205 cases
    Authors: Çakır Kıymaz, Y., Bolat, S., Katırcı, B., Büyüktuna, S.A., Elaldi, N.
    Year: 2025
  3. Title: A rare case of necrotizing pneumonia due to brucellosis with blood and urine culture positivity
    Authors: Çakır Kıymaz, Y., Yeşildağ, S., Hasbek, M., Büyüktuna, S.A., Elaldı, N.
    Year: 2024
  4. Title: Evaluation of Risk Factors Determining Focal Organ Involvement in Patients Diagnosed with Brucellosis | Bruselloz Tanılı Hastalarda Fokal Organ Tutulumunu Belirleyen Risk Faktörlerinin Değerlendirilmesi
    Authors: Çakır-Kıymaz, Y., Sungur, M.A.
    Year: 2024
  5. Title: Exploring free amino acid profiles in Crimean-Congo hemorrhagic fever patients: Implications for disease progression
    Authors: Büyüktuna, S.A., Yerlitaş, S.İ., Zararsız, G.E., Zararız, G., Doğan, H.O.
    Year: 2024
  6. Title: Exploring free amino acid profiles in CCHF patients: Implications for disease progression
    Authors: Büyüktuna, S.A., Yerlitaş, S.İ., Zararsız, G.E., Zararız, G., Doğan, H.O.
    Year: 2024
  7. Title: A Case of Hantavirus Renal Syndrome Detected in the COVID-19 Pandemic | COVID-19 Pandemisinde Saptanan Hantavirüs Renal Sendrom Olgusu
    Authors: Çakir, Y., İnce, N.
    Year: 2024
  8. Title: Frequency of Hepatosteatosis and Relationship Between Laboratory Parameters and Hepatosteatosis in Chronic Hepatitis B Patients | Kronik Hepatit B Hastalarında Hepatosteatoz Sıklığı ve Laboratuvar Parametrelerin Hepatosteatoz ile İlişkisinin Değerlendirilmesi
    Authors: Çakır, Y., Sungur, M.A., Öz, M., Büyüktuna, S.A.
    Year: 2024
  9. Title: Surgical Antimicrobial Prophylaxis Compliance in Turkey: Data from the Prospective, Observational, Multicenter Survey Including 7,978 Surgical Patients
    Authors: Çelik Ekinci, S., Yenilmez, E., Akengin Öcal, G., Raşa, H.K., Köse, Ş.
    Year: 2024
  10. Title: Multiple Cerebral Hydatic Cyst Developed After Operation of Cardiac Hydatic Cyst: A Case Report | Kardiyak Hidatik Kist Operasyonu Sonrası Gelişen Multiple Serebral Kist Hidatik: Olgu Sunumu
    Authors: Mutlu, İ., Koyuncu, Ö.R., Çakır, Y.
    Year: 2024

 

Rhonda Cooper-DeHoff | Genetics and pharmacogenetics | Best Researcher Award

Published on by World Science Awards

Dr. Rhonda Cooper-DeHoff | Genetics and Pharmacogenetics | Best Researcher Award

Director and Clinical Chair at Fitzpatrick Referrals Ltd, United Kingdom

Professor Noel Fitzpatrick is a distinguished veterinary orthopaedic surgeon with extensive expertise in small animal orthopaedics and sports medicine. Holding numerous prestigious qualifications, including Fellowships and Honorary Doctorates, he has made significant contributions through his roles as Emeritus Professor at the University of Surrey and founder of the Humanimal Trust. With a prolific publication record in veterinary surgery and orthopaedics, his research spans innovative treatments such as stem cell therapy and custom implants for complex conditions. His work in vector control, waste management, and water quality, though less prominent, reflects a commitment to broader environmental health. Fitzpatrick’s collaborative efforts are evident in his leadership of multiple institutions and involvement in interdisciplinary research. Recognized globally for his pioneering approaches and clinical advancements, he has been honored with numerous awards and accolades, solidifying his reputation as a leading figure in veterinary medicine.

Education

Dr. Rhonda M. Cooper-DeHoff has an impressive educational background, laying a strong foundation for her illustrious career in pharmacotherapy and translational research. She began her academic journey at the University of California, San Diego, where she earned a Bachelor of Arts in General Biology from Revelle College in 1982. She then pursued her Doctor of Pharmacy degree at the University of California, San Francisco, completing it in 1986. Dr. Cooper-DeHoff further advanced her expertise by obtaining a Master of Science in Medical Science with a concentration in Clinical Investigation from the University of Florida in 2007. This advanced training, coupled with her extensive post-graduate experience, including a fellowship in the Advanced Postgraduate Program in Clinical Investigation at the University of Florida College of Medicine and a fellowship from the American Heart Association, has equipped her with the knowledge and skills essential for her research and academic contributions in cardiovascular medicine and pharmacogenomics.

Professional Experience

Dr. Rhonda M. Cooper-DeHoff is a distinguished Associate Professor with Tenure in the Department of Pharmacotherapy and Translational Research at the University of Florida’s College of Pharmacy. Her professional journey includes a joint faculty appointment in the Division of Cardiovascular Medicine within the College of Medicine. Dr. Cooper-DeHoff’s career highlights include serving as Associate Director of the Center for Pharmacogenetics, Director of the Graduate Program in Precision Medicine, and roles such as Research Associate Professor and Research Assistant Professor at UF. Her earlier positions involved directing the INVEST Pharmacy Coordinating Center and managing the Clinical Trials Program. Dr. Cooper-DeHoff has contributed significantly to clinical research and education, particularly in cardiovascular and pharmacogenomics fields. Her leadership in various research projects, such as those funded by NIH and PCORI, showcases her expertise in precision medicine, hypertension, and metabolic research.

Research Interests

Dr. Rhonda M. Cooper-DeHoff’s research interests are centered on cardiovascular pharmacotherapy, precision medicine, and the optimization of hypertension management. She focuses on the pharmacogenomic evaluation of antihypertensive responses, aiming to personalize treatment strategies based on genetic profiles. Her work extensively involves clinical trials and comparative effectiveness research, investigating blood pressure control strategies and metabolic impacts of antihypertensive drugs. Dr. Cooper-DeHoff is also engaged in research related to the implementation of genomic medicine in clinical settings, striving to integrate biomarkers and lifestyle factors into personalized care. Her projects address health disparities and rural health challenges, reflecting her commitment to improving cardiovascular health outcomes through innovative and evidence-based approaches. Through her research, Dr. Cooper-DeHoff contributes to advancing precision medicine and enhancing patient care in cardiovascular medicine.

Research Skills

Dr. Rhonda M. Cooper-DeHoff possesses exceptional research skills that span various aspects of clinical and translational science. Her expertise in pharmacogenomics, particularly in the context of antihypertensive drug responses, highlights her adeptness at integrating genetic and clinical data to personalize treatment strategies. Dr. Cooper-DeHoff’s proficiency in managing large-scale, multi-center research projects is evidenced by her role in the NIH-funded PEAR study and her leadership in the PCORI PaCR initiative. Her ability to design and execute clinical trials, coupled with her experience in genomic medicine, underscores her capability to drive impactful research in cardiovascular medicine. Additionally, her involvement in projects such as the UF Moonshot Initiative and the Health Equity Research Institute demonstrates her commitment to addressing health disparities and optimizing clinical care. Dr. Cooper-DeHoff’s extensive publication record and her role in numerous research committees further reflect her deep engagement with advancing medical science.

Awards and Recognition

Dr. Cooper-DeHoff has received numerous awards and honors that recognize her contributions to research, mentorship, and clinical practice. Notable accolades include the UF College of Pharmacy Faculty Mentor of the Year, UF Research Foundation Professor Award, and the Russell R. Miller Award from the American College of Clinical Pharmacy. These awards reflect her excellence and leadership in the field.

Conclusion

Dr. Rhonda M. Cooper-DeHoff’s extensive research contributions, impactful collaborations, applied research achievements, and numerous recognitions make her a highly suitable candidate for the Research for Best Researcher Award. Her work in cardiovascular pharmacotherapy and translational research has significantly advanced the field and improved patient care, demonstrating her outstanding qualifications for this prestigious award.

Publications Top Notes

  1. Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinic
    • Authors: Cicali, E.J., Eddy, E., Gong, Y., George, T.J., Cooper-DeHoff, R.M.
    • Journal: Clinical and Translational Science
    • Volume: 17(7)
    • Article: e13890
    • Year: 2024
  2. Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers
    • Authors: Mehanna, M., McDonough, C.W., Smith, S.M., Johnson, J.A., Cooper-DeHoff, R.M.
    • Journal: Clinical and Translational Science
    • Volume: 17(5)
    • Article: e13816
    • Year: 2024
  3. Circulating microRNA Biomarkers of Thiazide Response in Hypertension
    • Authors: Chekka, L.M.S., Tantawy, M., Langaee, T., Cooper-Dehoff, R.M., Johnson, J.A.
    • Journal: Journal of the American Heart Association
    • Volume: 13(4)
    • Article: e032433
    • Year: 2024
    • Citations: 2
  4. Initial Antihypertensive Prescribing in Relation to Blood Pressure among Florida Medicaid and Medicare Recipients in the OneFlorida+ Research Consortium
    • Authors: Smith, K.M., Keshwani, S., Walsh, M.G., Cooper-Dehoff, R.M., Smith, S.M.
    • Journal: Hypertension
    • Volume: 81(2)
    • Pages: E7-E9
    • Year: 2024
  5. Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data
    • Authors: Jafari, E., Cooper-DeHoff, R.M., Effron, M.B., Hogan, W.R., McDonough, C.W.
    • Journal: American Journal of Hypertension
    • Volume: 37(1)
    • Pages: 60-68
    • Year: 2024
    • Citations: 3
  6. In Reply: Probability of Reduced Follow-up Health Care Visits for Controlled Hypertensive Patients
    • Authors: Chamberlain, A.M., Cooper-DeHoff, R.M., Pletcher, M.J.
    • Journal: Mayo Clinic Proceedings
    • Volume: 98(6)
    • Pages: 949
    • Year: 2023
  7. Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale
    • Authors: Joseph, J., Pajewski, N.M., Dolor, R.J., Shivaswamy, V., Ramalingam, R.
    • Journal: Journal of the American Geriatrics Society
    • Volume: 71(6)
    • Pages: 1701-1713
    • Year: 2023
    • Citations: 17
  8. New Drugs Approved in 2022
    • Authors: Ebied, A.M., Elmariah, H., Cooper-DeHoff, R.M.
    • Journal: American Journal of Medicine
    • Volume: 136(6)
    • Pages: 545-550
    • Year: 2023
    • Citations: 1
  9. Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy
    • Authors: Deremer, D.L., Nguyen, N.K., Guha, A., Fradley, M.G., Gong, Y.
    • Journal: Journal of the American Heart Association
    • Volume: 12(10)
    • Article: e027981
    • Year: 2023
    • Citations: 5
  10. Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory
    • Authors: Chamberlain, A.M., Cooper-DeHoff, R.M., Fontil, V., Knowlton, K.U., Pletcher, M.J.
    • Journal: Mayo Clinic Proceedings
    • Volume: 98(5)
    • Pages: 662-675
    • Year: 2023
    • Citations: 7